49 results on '"Yang, Ju Dong"'
Search Results
2. Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women: Global Trends and Projections to 2040
3. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
4. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis
5. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis
6. Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC
7. COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States
8. Amanita Mushroom Toxin Poisoning in Los Angeles County
9. OS-055 Defining the thresholds for alcohol intake on the risk of liver-related mortality in people with metabolic risk factors
10. LBO-006 A prospective, blinded, multicenter U.S. evaluation of a multianalyte blood-based test for the detection of hepatocellular carcinoma (HCC) in patients with cirrhosis
11. TOP-063 The efficacy of Glucagon-like Peptide-1 receptor agonists in patients with compensated cirrhosis and obesity
12. Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine
13. Role of biomarkers in the diagnosis and management of HCC
14. MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: a population based study with 26.7 years of follow-up
15. Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018.
16. Global epidemiology of alcohol‐associated liver disease in adolescents and young adults.
17. Alpha-fetoprotein: Past, present, and future
18. Incidence of liver cancer in young adults according to the global burden of disease database 2019
19. Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization
20. Artificial intelligence in liver cancer research: a scientometrics analysis of trends and topics
21. Food Insecurity in Hispanic Populations Is Associated with an Increased Risk of Hepatic Steatosis: A Nationally Representative Study.
22. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma
23. Primary liver cancer spectrum: current knowledge and the next steps
24. Implications of drug intoxication on donor utilization and outcomes in liver transplantation.
25. Revised REACH-B Model for Hepatocellular Carcinoma Risk Prediction in Patients With Chronic Hepatitis B.
26. Reply to correspondence on “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis.
27. FRI-081 Lisinopril is associated with reduced hepatocellular carcinoma and mortality risk in patients with MASLD-related compensated cirrhosis: a multicenter, nationwide propensity score matching analysis
28. Reply
29. Tu1555 IMMUNOTHERAPY VERSUS LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER, NATIONWIDE PROPENSITY SCORE MATCHING ANALYSIS
30. Sa1557 EFFECTS OF METABOLIC RISK FACTORS ON THE RISK OF PROGRESSION TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
31. Sa1428 FEASIBILTY OF REAL-TIME TRANSDERMAL ALCOHOL MEASUREMENTS IN PANCREATITIS PATIENTS
32. Tu1544 CLINICAL BENEFITS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE IN A CONTEMPORARY COHORT OF AT-RISK PATIENTS
33. Su1523 THE PREVALENCE OF PNPLA3 GENETIC VARIANT IN CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
34. Sa1538 AWARENESS OF ADVANCED FIBROSIS AND CIRRHOSIS IN THE UNITED STATES: A NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2017-2020
35. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
36. Novel Biomarkers for Early Detection of Hepatocellular Carcinoma.
37. GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients.
38. Clonal hematopoiesis of indeterminate potential and risk of hepatocellular carcinoma: New kids on the block.
39. Addressing the Complexities of Pre-Liver Transplant Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Response to Recent Commentaries.
40. Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021.
41. Response to Mattiuzzi and Lippi.
42. Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis.
43. Development and validation of a biomarker index for HCC treatment response.
44. The Burden of Overweight and Obesity-Associated Gastrointestinal Cancers in Low and Lower-Middle-Income Countries: A Global Burden of Disease 2019 Analysis.
45. Role of biomarkers in the diagnosis and management of HCC.
46. Reply to correspondence on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”
47. Correction to: Amanita Mushroom Toxin Poisoning in Los Angeles County.
48. Correspondence on Letter regarding "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma".
49. Recent advances in the management of hepatocellular carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.